Cargando…

The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial

A major obstacle to the development of new treatments for venous leg ulcers is the difficulty in generating evidence for their effectiveness. Randomised controlled trials using complete healing as the endpoint are seldom powered to be successful, owing to the heterogeneity of cohorts. A novel approa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bull, Richard Hillson, Clements, Donna, Collarte, Agnes Juguilon, Harding, Keith Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333027/
https://www.ncbi.nlm.nih.gov/pubmed/36785909
http://dx.doi.org/10.1111/iwj.14107
_version_ 1785070565431705600
author Bull, Richard Hillson
Clements, Donna
Collarte, Agnes Juguilon
Harding, Keith Gordon
author_facet Bull, Richard Hillson
Clements, Donna
Collarte, Agnes Juguilon
Harding, Keith Gordon
author_sort Bull, Richard Hillson
collection PubMed
description A major obstacle to the development of new treatments for venous leg ulcers is the difficulty in generating evidence for their effectiveness. Randomised controlled trials using complete healing as the endpoint are seldom powered to be successful, owing to the heterogeneity of cohorts. A novel approach to the evaluation of treatments is presented, using a self‐controlled trial model and two metrics of short‐term healing rate as alternate endpoints: rate of wound margin advance, and percentage area reduction over 4 weeks. Two different treatment regimens are compared: multi‐layer compression alone, versus multi‐layer compression combined with activation of the venous leg pump by neuromuscular stimulation. With 60 patients, adding neuromuscular stimulation to multilayer compression resulted in a significant two‐fold increase in the rate of wound healing over a 4‐week period, both in terms of wound margin advance and in terms of percentage area reduction. The use of these short‐term intermediate endpoint metrics together with a self‐controlled study design offers potential for distinguishing between the relative efficacies of interventions more rapidly, with greater sensitivity, and with fewer subjects than a conventional RCT cohort model.
format Online
Article
Text
id pubmed-10333027
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-103330272023-07-12 The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial Bull, Richard Hillson Clements, Donna Collarte, Agnes Juguilon Harding, Keith Gordon Int Wound J Original Articles A major obstacle to the development of new treatments for venous leg ulcers is the difficulty in generating evidence for their effectiveness. Randomised controlled trials using complete healing as the endpoint are seldom powered to be successful, owing to the heterogeneity of cohorts. A novel approach to the evaluation of treatments is presented, using a self‐controlled trial model and two metrics of short‐term healing rate as alternate endpoints: rate of wound margin advance, and percentage area reduction over 4 weeks. Two different treatment regimens are compared: multi‐layer compression alone, versus multi‐layer compression combined with activation of the venous leg pump by neuromuscular stimulation. With 60 patients, adding neuromuscular stimulation to multilayer compression resulted in a significant two‐fold increase in the rate of wound healing over a 4‐week period, both in terms of wound margin advance and in terms of percentage area reduction. The use of these short‐term intermediate endpoint metrics together with a self‐controlled study design offers potential for distinguishing between the relative efficacies of interventions more rapidly, with greater sensitivity, and with fewer subjects than a conventional RCT cohort model. Blackwell Publishing Ltd 2023-02-13 /pmc/articles/PMC10333027/ /pubmed/36785909 http://dx.doi.org/10.1111/iwj.14107 Text en © 2023 The Authors. International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Bull, Richard Hillson
Clements, Donna
Collarte, Agnes Juguilon
Harding, Keith Gordon
The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial
title The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial
title_full The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial
title_fullStr The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial
title_full_unstemmed The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial
title_short The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial
title_sort impact of a new intervention for venous leg ulcers: a within‐patient controlled trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333027/
https://www.ncbi.nlm.nih.gov/pubmed/36785909
http://dx.doi.org/10.1111/iwj.14107
work_keys_str_mv AT bullrichardhillson theimpactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial
AT clementsdonna theimpactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial
AT collarteagnesjuguilon theimpactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial
AT hardingkeithgordon theimpactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial
AT bullrichardhillson impactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial
AT clementsdonna impactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial
AT collarteagnesjuguilon impactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial
AT hardingkeithgordon impactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial